Clinical Trials Using Liraglutide

Clinical trials are research studies that involve people. The clinical trials on this list are studying Liraglutide. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Liraglutide and Smoking Cessation Behavioral Counseling in Helping Smokers to Quit Smoking

    This phase II trial studies how well liraglutide and smoking cessation behavioral counseling sessions work in helping smokers to quit smoking. Liraglutide belongs to a class of medications called glucagon‐like peptide‐1 (GLP‐1) receptor agonists. The body naturally produces GLP‐1, which helps regulate the appetite. Liraglutide works like GLP‐1. Smoking cessation behavioral counseling sessions are designed to enhance awareness of the harmful effects of smoking, assist in developing skills to quit smoking, emphasize the benefits of quitting, and help avoid relapse. Giving liraglutide together with smoking cessation behavioral counseling sessions may help to prevent weight gain during a smoker’s attempt to quit smoking and may help people stay smoke free.
    Location: University of Pennsylvania / Abramson Cancer Center, Philadelphia, Pennsylvania